Elicio Therapeutics, Inc.
ELTX
$2.18
-$0.17-7.23%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 14.23M | 13.70M | 12.81M | 11.82M | 11.95M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 37.92M | 37.58M | 37.71M | 42.35M | 44.65M |
| Operating Income | -37.92M | -37.58M | -37.71M | -42.35M | -44.65M |
| Income Before Tax | -37.84M | -40.19M | -39.57M | -45.86M | -54.61M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -37.84 | -40.19 | -39.57 | -45.86 | -54.61 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -37.84M | -40.19M | -39.57M | -45.86M | -54.61M |
| EBIT | -37.92M | -37.58M | -37.71M | -42.35M | -44.65M |
| EBITDA | -37.74M | -37.38M | -37.51M | -42.11M | -44.38M |
| EPS Basic | -2.18 | -2.41 | -2.62 | -3.15 | -3.94 |
| Normalized Basic EPS | -1.36 | -1.52 | -1.66 | -1.99 | -2.48 |
| EPS Diluted | -2.18 | -2.41 | -2.62 | -3.15 | -3.94 |
| Normalized Diluted EPS | -1.36 | -1.52 | -1.66 | -1.99 | -2.48 |
| Average Basic Shares Outstanding | 69.66M | 66.47M | 61.21M | 59.35M | 56.24M |
| Average Diluted Shares Outstanding | 69.66M | 66.47M | 61.21M | 59.35M | 56.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |